Laura A Williams
CIK 1869194 · Chief Patient Officer · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.84M
Companies
2
Total Filings
40
Lifetime Open-Market Net
-$3.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-20 | ARDX | Notice (144) | −6,354 | -$37.6K | EDGAR |
| 2025-08-28 | ARDX | Mixed | −30,000 | -$440.2K | EDGAR |
| 2025-08-26 | ARDX | Notice (144) | −80,000 | -$484.8K | EDGAR |
| 2025-08-25 | ARDX | Sell (S) | −6,261 | -$37.1K | EDGAR |
| 2025-05-22 | ARDX | Sell (S) | −6,421 | -$26.2K | EDGAR |
| 2025-02-27 | ARDX | Grant (A) | +105,200 | $0 | EDGAR |
| 2025-02-21 | ARDX | Sell (S) | −4,941 | -$27.8K | EDGAR |
| 2024-11-22 | ARDX | Sell (S) | −7,366 | -$35.3K | EDGAR |
| 2024-08-22 | ARDX | Sell (S) | −7,412 | -$43.4K | EDGAR |
| 2024-06-07 | ARDX | Mixed | −45,000 | -$758.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.